These exciting results led to the present study, in which we attempted to evaluate the synergistic effect of HSV-TK/GCV-mediated tumor suicide gene therapy and RFH in-vitro and rat models of HCC that can be monitored using multimodality molecular imaging. This evidence concerns the gene TKT and hepatocellular carcinoma.